SIGA Technologies

SIGA · NASDAQ

$3.15+$0.01 (+0.32%)TodayMarket closed ·
Prev close $3.14

Latest news

  • News

    Full Transcript: SIGA Technologies Q2 2026 Earnings Call

  • News

    SIGA Technologies Q2 EPS $0.17 Down From $0.49 YoY, Sales $41.002M Down From $81.120M YoY

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three and Six Months Ended June 30, 2026

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update

  • NewsAvi Kapoor

    Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket

  • NewsAlex Perry

    Why Are Siga Technologies Shares Trading Higher?

  • NewsAvi Kapoor

    Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    SIGA Declares Special Cash Dividend of $0.60 Per Share

  • News

    SIGA Technologies Q4 EPS $(0.08) Down From $0.63 YoY, Sales $3.800M Down From $81.400M YoY

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update

  • News

    Earnings Scheduled For March 10, 2026

  • News

    SIGA Technologies Q3 EPS $(0.09) Down From $0.02 YoY, Sales $2.620M Down From $10.010M YoY

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

  • News

    Earnings Scheduled For November 6, 2025

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

  • News

    Earnings Scheduled For August 5, 2025

  • Press releaseGlobe Newswire

    SIGA Reports Financial Results for Three Months Ended March 31, 2025

  • News

    Earnings Scheduled For May 8, 2025

  • News

    Watching SIGA Technologies; Shares See Volume To The Upside, Earlier Reports Say NC Department Of Health And Human Services Said Mpox Found In Wastewater In North Carolina From Samples Collected On March 25, March 28 & April 8 From Treatment Plant In Greenville; No Mpox Clade I Cases Have Been Reported To Date

  • Press releaseGlobe Newswire

    SIGA Declares Special Cash Dividend of $0.60 Per Share

  • Press releaseGlobe Newswire

    SIGA Appoints Retired General John M. Keane to its Board of Directors

  • NewsVandana Singh

    NIH Trial Finds Tecovirimat Ineffective As Monotherapy For Mpox

  • News

    'Tecovirimat Is Safe But Ineffective As Treatment For Clade II Mpox' - NIH

  • NewsAvi Kapoor

    Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

  • News

    'NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution Or Pain'

  • Press releaseGlobe Newswire

    SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Is Investigating CSX, Stride, and SIGA and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

  • Press releasePRNewswire

    Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

  • Press releaseGlobe Newswire

    SIGA ALERT: Bragar Eagel & Squire, P.C. is Investigating SIGA Technologies, Inc. on Behalf of SIGA Stockholders and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

  • Press releaseGlobe Newswire

    SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

  • Press releaseBusiness Wire

    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)

  • Press releaseBusiness Wire

    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

  • Press releaseBusiness Wire

    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

  • Press releaseBusiness Wire

    The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

  • Press releasePRNewswire

    Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

  • Press releasePRNewswire

    Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

  • NewsChris Katje

    WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'

  • NewsMichael Juliano

    Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening

  • NewsMark Putrino

    Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

  • NewsAvi Kapoor

    H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday

  • News

    ECDC Warns of Likely Mpox Cases in EU/EEA from Africa, But Low Risk of Sustained Transmission with Quick Diagnosis and Control

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue

  • NewsAdam Eckert

    Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?

  • NewsAvi Kapoor

    Nasdaq Jumps Over 2%; Walmart Earnings Top Views

  • NewsAvi Kapoor

    Dow Surges Over 500 Points; US Retail Sales Rise In July

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.